Cite this article
28
Downloads
11
Citations
65
Views
Announcements
Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.
Original Research
Novasure impedance control system versus microwave endometrial ablation for the treatment of dysfunctional uterine bleeding: a double-blind, randomized controlled trial
D. Athanatos1,*, G. Pados1, C.A. Venetis1, P. Stamatopoulos1, D. Rousso2, D. Tsolakidis1, C.P. Stamatopoulos1, B.C. Tarlatzis1
Show Less
1
1st Dept of Obstetrics and Gynecology, “Papageorgiou” University Hospital, Aristotle University of Thessaloniki, Thessaloniki
2
3rd Dept of Obstetrics and Gynecology, “Hippocration” University Hospital, Aristotle University of Thessaloniki, Thessaloniki (Greece)
Clin. Exp. Obstet. Gynecol. 2015, 42(3), 347–351;
https://doi.org/10.12891/ceog1866.2015
Published: 10 June 2015
Abstract
Purpose of investigation: To compare the efficacy and safety of two different second-generation ablation devices, Novasure impedance control system and microwave endometrial ablation (MEA), in cases of abnormal uterine bleeding (AUB). Materials and Methods: This is a randomized controlled trial that took place in a single Gynecological Department of a University Hospital. Sixty-six women with dysfunctional uterine bleeding (DUB), unresponsive to medical treatment, were included in the trial. The ratio of women allocated to bipolar radio-frequency ablation or MEA was 1:1. Follow-up assessments were carried out at three and 12 months post-ablation. The present main outcome measure was amenorrhea rates 12-months post-treatment. Results: The rate of amenorrhea at 12- months post-ablation was significantly higher in women treated by Novasure (25/33; 75.8%) as compared to those treated by MEA (8/33; 24.2%) (rate difference: +51.5%, 95% CI: +27.8 to +67.7). Conclusion: In women with DUB, endometrial ablation with Novasure bipolar radiofrequency impedance-controlled system is associated with increased rates of amenorrhea at 12-months post-treatment as compared to the MEA method.
Keywords
Abnormal uterine bleeding
Novasure
Microwave endometrial ablation